Voyager Therapeutics is trading at $3.36 (-5.08%) with no clear company-specific catalyst identified.
- No major announcement dated September 3, 2026, was found; the September 1 release only announced investor-conference appearances beginning September 8, with no new clinical, regulatory, financial, or partnership news.
- The decline came despite broader equities and biotechnology moving higher; older earnings and analyst-estimate changes do not directly explain the move.